Company Filing History:
Years Active: 2005-2010
Title: Jens-Erik Sørensen: Innovator in Biocompatible Hydrogels
Introduction
Jens-Erik Sørensen is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of biocompatible materials, particularly in the development of hydrogels. With a total of 3 patents, Sørensen's work focuses on innovative solutions for medical applications.
Latest Patents
One of Sørensen's latest patents is titled "Polyacrylamide hydrogel and its use as an endoprosthesis." This invention describes a biocompatible hydrogel that consists of a specified content of polyacrylamide and pyrogen-free water. The patent also outlines a method for creating the hydrogel, which can be used as an injectable or implantable endoprosthesis. This hydrogel has potential applications in treating cosmetic or functional defects, as well as medical indications such as mammoplastic reconstruction and body contouring.
Another significant patent is "Low polydispersity poly-HEMA compositions." This invention relates to compositions that include poly-HEMA with a peak molecular weight between about 25,000 and 100,000. The patent details processes for functionalizing and purifying poly-HEMA to create crosslinkable prepolymers, which can be used to produce hydrogels and various articles.
Career Highlights
Throughout his career, Jens-Erik Sørensen has worked with prominent companies in the medical field. Notably, he has been associated with Johnson and Johnson Vision Care, Inc. and Contura A/S. His experience in these organizations has contributed to his expertise in developing innovative hydrogel technologies.
Collaborations
Sørensen has collaborated with various professionals in his field, including Ture Kindt-Larsen. These partnerships have facilitated the advancement of his research and the successful development of his patented technologies.
Conclusion
Jens-Erik Sørensen is a distinguished inventor whose work in biocompatible hydrogels has the potential to impact medical treatments significantly. His innovative patents reflect his commitment to advancing technology in healthcare.